Medical University of Vienna
🇦🇹Austria
- Country
- 🇦🇹Austria
- Ownership
- Private
- Established
- 1365-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.meduniwien.ac.at
Methylphenidate as Treatment Option of Fatigue in Multiple Sclerosis
Phase 2
- Conditions
- FatigueMultiple Sclerosis
- Interventions
- First Posted Date
- 2013-06-17
- Last Posted Date
- 2015-05-12
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 96
- Registration Number
- NCT01879202
- Locations
- 🇦🇹
Medical University of Vienna, Department of Neurology, Vienna, Austria
Cytokine Removal in Cardiopulmonary Bypass Patients
Phase 3
Completed
- Conditions
- Elective Cardiac Surgical Interventions
- Interventions
- Device: CytoSorb
- First Posted Date
- 2013-06-17
- Last Posted Date
- 2017-02-23
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 46
- Registration Number
- NCT01879176
- Locations
- 🇦🇹
Divison of Cardiothoracic Anaesthesia and Intensive Care, Medical University of Vienna, Vienna, Austria
A Pilot Study Simulating Multifocal Intraocular Lenses in Healthy Subjects
Completed
- Conditions
- Lenses, IntraocularContrast SensitivityVisual Acuity
- Interventions
- First Posted Date
- 2013-06-10
- Last Posted Date
- 2013-08-29
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 30
- Registration Number
- NCT01873781
- Locations
- 🇦🇹
Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
Bortezomib in Late Antibody-mediated Kidney Transplant Rejection
Phase 2
Completed
- Conditions
- Late Rejection of Renal TransplantAntibody-mediated Rejection
- Interventions
- Drug: PlaceboDrug: Bortezomib
- First Posted Date
- 2013-06-07
- Last Posted Date
- 2017-03-23
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 44
- Registration Number
- NCT01873157
- Locations
- 🇦🇹
Medical University of Vienna, Department of Nephrology and Dialysis, Vienna, Austria
The Impact of IVIG Treatment on Critical Illness Polyneuropathy and/or Myopathy in Patients With MOF and SIRS/Sepsis
Phase 1
Terminated
- Conditions
- Polyneuropathies
- Interventions
- Drug: IgM-enriched Intravenous ImmunoglobulinsDrug: Human Albumin
- First Posted Date
- 2013-06-04
- Last Posted Date
- 2013-06-04
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 38
- Registration Number
- NCT01867645
- Locations
- 🇦🇹
Medical University of Vienna, Vienna, Austria
Pharmacokinetics of Cidofovir During Continuous Venovenous Hemofiltration
Phase 4
Completed
- Conditions
- Acute Renal FailureCytomegalovirus Retinitis
- Interventions
- Other: Cidofovir pharmacokinetics
- First Posted Date
- 2013-05-31
- Last Posted Date
- 2013-06-05
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 1
- Registration Number
- NCT01866397
- Locations
- 🇦🇹
Medical University of Vienna, Vienna, Austria
Influence of Lachrymal Substitutes on Tear Film Thickness in Patients With Moderate Dry Eye Syndrome
Phase 4
Completed
- Conditions
- Dry Eye Syndrome
- Interventions
- Device: Hydrabak®Device: Thealoz Duo®Device: Hyabak®
- First Posted Date
- 2013-05-29
- Last Posted Date
- 2013-11-27
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 60
- Registration Number
- NCT01864330
- Locations
- 🇦🇹
Department of Clinical Pharmacology, Vienna, Austria
Target Temperature Management In Myocardial Infarction - A Pilot Study
Not Applicable
Completed
- Conditions
- ST-elevation Myocardial Infarction
- Interventions
- Device: EMCOOLS flex pad; Philips Innercool RTx
- First Posted Date
- 2013-05-29
- Last Posted Date
- 2013-05-29
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 19
- Registration Number
- NCT01864343
- Locations
- 🇦🇹
Medical University of Vienna, Vienna, Austria
Assessment of Optic Nerve Radiation in Patients With Glaucoma and Ocular Hypertension by 7 Tesla Diffusion Tensor Imaging
Phase 2
Terminated
- Conditions
- Primary Open Angle GlaucomaOcular HypertensionNormal Tension Glaucoma
- Interventions
- Device: 7-Tesla MRIOther: Optical Coherence TomographyOther: Heidelberg Retina TomographyOther: Scanning Laser PolarimetryOther: Humphrey PerimetryOther: Applanation Tonometry
- First Posted Date
- 2013-05-29
- Last Posted Date
- 2019-08-22
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 120
- Registration Number
- NCT01864317
- Locations
- 🇦🇹
Department of Clinical Pharmacology, Vienna, Austria
Periodontal Disease as a Risk Indicator for Erectile Dysfunction - A Cross-sectional Study on 100 Patients
- Conditions
- Erectile DysfunctionPeriodontitishsCRP
- First Posted Date
- 2013-05-13
- Last Posted Date
- 2014-05-14
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 100
- Registration Number
- NCT01852240
- Locations
- 🇦🇹
Krankenanstalt Rudolfstiftung, Vienna, Austria
© Copyright 2025. All Rights Reserved by MedPath